<DOC>
	<DOC>NCT01900704</DOC>
	<brief_summary>To investigate the efficacy and safety of SER120 nasal spray formulations in patients with nocturia</brief_summary>
	<brief_title>Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4</brief_title>
	<detailed_description />
	<mesh_term>Nocturia</mesh_term>
	<criteria>Male and female 50 years or older Nocturia of 6 or more months duration averaging greater than 2 nocturic episodes per night CHF Diabetis Insipidus Renal insufficiency Hepatic insufficiency Incontinence Illnesses requiring systemic steroids Malignancy within the past 5 years Sleep apnea Nephrotic syndrome Unexplained pelvic mass Urinary bladder neurological dysfunction Urinary bladder surgery or radiotherapy Pregnant or breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>